Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
J Neurovirol ; 27(1): 154-159, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-33528827

RESUMEN

As the SARS-COV-2 becomes a global pandemic, many researchers have a concern about the long COVID-19 complications. Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a persistent, debilitating, and unexplained fatigue disorder. We investigated psychological morbidities such as CFS and post-traumatic stress disorder (PTSD) among survivors of COVID-19 over 6 months. All COVID-19 survivors from the university-affiliated hospital of Tehran, Iran, were assessed 6 months after infection onset by a previously validated questionnaire based on the Fukuda guidelines for CFS/EM and DSM-5 Checklist for PTSD (The Post-traumatic Stress Disorder Checklist for DSM-5 or PCL-5) to determine the presence of stress disorder and chronic fatigue problems. A total of 120 patients were enrolled. The prevalence rate of fatigue symptoms was 17.5%. Twelve (10%) screened positive for chronic idiopathic fatigue (CIF), 6 (5%) for CFS-like with insufficient fatigue syndrome (CFSWIFS), and 3 (2.5%) for CFS. The mean total scores in PCL-5 were 9.27 ± 10.76 (range:0-44), and the prevalence rate of PTSD was 5.8%. There was no significant association after adjusting between CFS and PTSD, gender, comorbidities, and chloroquine phosphate administration. The obtained data revealed the prevalence of CFS among patients with COVID-19, which is almost similar to CFS prevalence in the general population. Moreover, PTSD in patients with COVID-19 is not associated with the increased risk of CFS. Our study suggested that medical institutions should pay attention to the psychological consequences of the COVID-19 outbreak.


Asunto(s)
COVID-19/psicología , Tos/psicología , Demencia/psicología , Disnea/psicología , Síndrome de Fatiga Crónica/psicología , Fiebre/psicología , Trastornos por Estrés Postraumático/psicología , Adulto , Anciano , Antivirales/uso terapéutico , COVID-19/complicaciones , COVID-19/virología , Tos/complicaciones , Tos/tratamiento farmacológico , Tos/virología , Demencia/complicaciones , Demencia/tratamiento farmacológico , Demencia/virología , Combinación de Medicamentos , Disnea/complicaciones , Disnea/tratamiento farmacológico , Disnea/virología , Síndrome de Fatiga Crónica/complicaciones , Síndrome de Fatiga Crónica/tratamiento farmacológico , Síndrome de Fatiga Crónica/virología , Femenino , Fiebre/complicaciones , Fiebre/tratamiento farmacológico , Fiebre/virología , Humanos , Hidroxicloroquina/uso terapéutico , Lopinavir/uso terapéutico , Masculino , Persona de Mediana Edad , Oseltamivir/uso terapéutico , Proyectos de Investigación , Ritonavir/uso terapéutico , SARS-CoV-2/efectos de los fármacos , SARS-CoV-2/patogenicidad , Índice de Severidad de la Enfermedad , Trastornos por Estrés Postraumático/complicaciones , Trastornos por Estrés Postraumático/tratamiento farmacológico , Trastornos por Estrés Postraumático/virología , Encuestas y Cuestionarios , Sobrevivientes/psicología , Tratamiento Farmacológico de COVID-19
2.
Anat Sci Int ; 2024 May 23.
Artículo en Inglés | MEDLINE | ID: mdl-38782867

RESUMEN

Epilepsy is a common neurological disorder that significantly affects the quality of life of patients. In this study, we aim to evaluate the effectiveness of dental pulp stem cell (DPSC) transplantation in decreasing inflammation and cell death in brain cells, thus reducing seizure damage. We induced seizures in rats using intraperitoneal injections of pentylenetetrazole (PTZ). In the PTZ + DPSC group, we conducted bilateral hippocampal transplantation of DPSCs in PTZ-lesioned rat models. After 1 month, we performed post-graft analysis and measured some behavioral factors, such as working memory and long-term memory, using a T-maze test and passive avoidance test, respectively. We investigated the immunohistopathology and distribution of astrocyte cells through light microscopy and Sholl analysis. Additionally, we employed the Voronoi tessellation method to estimate the spatial distribution of the cells in the hippocampus. Compared to the control group, we observed a reduction in astrogliosis, astrocyte process length, the number of branches, and intersections distal to the soma in the hippocampus of the PTZ + DPSC group. Further analysis indicated that the grafted DPSCs decreased the expression of caspase-3 in the hippocampus of rats with induced seizures. Moreover, the DPSCs transplant protected hippocampal pyramidal neurons against PTZ toxicity and improved the spatial distribution of the hippocampal neurons. Our findings suggest that DPSCs transplant can be an effective modifier of astrocyte reactivation and inflammatory responses.

3.
Reprod Sci ; 31(5): 1278-1289, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38228974

RESUMEN

Concerns have been raised about potentially irreversible brain damage and damage to the neuroendocrine system during development when treating attention-deficit/hyperactivity disorder with lisdexamfetamine (LDX), a norepinephrine dopamine reuptake inhibitor. This study aims to elucidate the potential adverse effects of LDX on the male reproductive system due to its widespread use and potential for abuse. In this study, adult male rats were randomized into control and LDX groups. Thirty milligrams per kilogram LDX was administered orally for 3 weeks. After isolation of epididymal spermatozoa, the rats were euthanized and testicular tissues were collected for stereological and molecular analyses. The LDX group showed a decrease in sperm motility and an increase in DNA fragmentation compared to the control group. There was also a dramatic decrease in testosterone in the LDX group. Testicular expression of caspase-3 and TNF-α was significantly increased in the LDX group. According to our findings, prolonged use of LDX leads to reduced sperm quality. It also induces apoptosis, inflammatory response, and pathological changes in the testicular tissue. What we have observed in this study is noteworthy but requires further investigation, particularly in people who use LDX over a longer period of time.


Asunto(s)
Apoptosis , Dimesilato de Lisdexanfetamina , Motilidad Espermática , Espermatozoides , Testículo , Animales , Masculino , Apoptosis/efectos de los fármacos , Espermatozoides/efectos de los fármacos , Espermatozoides/patología , Dimesilato de Lisdexanfetamina/toxicidad , Testículo/efectos de los fármacos , Testículo/patología , Testículo/metabolismo , Motilidad Espermática/efectos de los fármacos , Ratas Sprague-Dawley , Inflamación/inducido químicamente , Inflamación/patología , Ratas , Testosterona , Fragmentación del ADN/efectos de los fármacos , Caspasa 3/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA